Other molecular mechanisms have also emerged as responsible for the appearance of drug resistance in GBM patients, including loss of mismatch repair (MMR) proteins [42], mutation of the tumor suppressor gene TP53 [43], and overexpression of the MDR1 gene product P-glycoprotein (P-gp) [44]. The gene discussed is ABCB1; the disease is glioblastoma.